Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Rattus norvegicus

ABSTRACT: Whole-transcriptome analysis identifies re-expression of fetal splice variants in cardiac hypertrophy

PROVIDER: PRJNA181346 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR618534_1.fastq.gz	Fastqsanger.gz
	SRR618534_2.fastq.gz	Fastqsanger.gz
	SRR618535_1.fastq.gz	Fastqsanger.gz
	SRR618535_2.fastq.gz	Fastqsanger.gz
	SRR618536_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 18

Similar Datasets

Rattus norvegicus

Project description:Physiologic cardiac hypertrophy

| PRJNA87737 | ENA

Rattus norvegicus

Project description:miRNA-99 family diverges physiological cardiac hypertrophy to pathological cardiac hypertrophy

| PRJNA297403 | ENA

Rattus norvegicus

Project description:Exercise induced cardiac hypertrophy

| PRJNA87691 | ENA

Rattus norvegicus

Project description:Fibronectin Induced Cardiac Myocyte Hypertrophy

| PRJNA87131 | ENA

Rattus norvegicus

Project description:Rat models of cardiac hypertrophy

| PRJNA87689 | ENA

Rattus norvegicus

Project description:Fetal-Adult Cardiac Transcriptome Analysis in Rats with Contrasting Left Ventricular Mass Reveals New Candidates for Cardiac Hypertrophy

| PRJNA232301 | ENA

Whole-transcriptome analysis identifies re-expression of fetal splice variants in cardiac hypertrophy

Project description:Cardiac hypertrophy has been well-characterized at the level of transcription. During cardiac hypertrophy, genes normally expressed primarily during fetal heart development are re-expressed, and this fetal gene program is believed to be a critical component of the hypertrophic process. Recently, alternative splicing of mRNA transcripts has been shown to be temporally regulated during heart development, leading us to consider whether fetal patterns of splicing also reappear during hypertrophy.We hypothesized that patterns of alternative splicing occurring during heart development are recapitulated during cardiac hypertrophy. Here we present a whole-transcriptome study of isoform expression during pressure-overload cardiac hypertrophy induced by 10 days of transverse aortic constriction (TAC) in rats and in developing fetal rat hearts compared to sham-operated adult rat hearts, using high-throughput sequencing of poly(A) tail mRNA. Quantification of isoform expression in fetal rat hearts, pressure-overloaded rat hearts, and sham-operated rat hearts by Illumina GAIIx in triplicate

2013-05-14 | E-GEOD-42411 | biostudies-arrayexpress

Whole-transcriptome analysis identifies re-expression of fetal splice variants in cardiac hypertrophy

2013-05-14 | GSE42411 | GEO

Gene expression in the right ventricle of Rattus norvegicus during development of right ventricular heart failure and treatment

Project description:Right ventricular heart failure (RVF) associated with pulmonary hypertension (PH) is characterized by a distinct gene expression pattern when compared with functional compensatory hypertrophy. Carvedilol treatment after RVF has been established reduces right ventricle (RV) hypertrophy and improves the RV function. In addition, carvedilol treatment has been shown to alter the gene expression of select genes. We sought to identify, on a genome-wide basis, the effect of carvedilol on gene expression. RVF was induced in male Sprague-Dawley rats by the combination of VEGF-receptor blockade and chronic hypoxia; thereafter, one group was treated with carvedilol. RNA was isolated from the RV and subjected to microarray analysis. A prediction analysis of the carvedilol-treated RVs showed that carvedilol treated RVs most resembled in their expression pattern the RVF pattern. However, an analysis beyond the boundaries of the prediction set revealed a small set of genes associated with carvedilol reversal of RVF. Pathway analysis of this set of genes revealed expression changes of genes involved in cardiac hypertrophy, mitochondrial dysfunction, protein ubiquitination, and sphingolipid metabolism. Genes encoding proteins in the cardiac hypertrophy and protein ubiquitination pathways were downregulated in the RV by carvedilol, while genes encoding proteins in the mitochondrial dysfunction and sphingolipid metabolism pathways were upregulated by carvedilol.

2013-05-06 | GSE42579 | GEO

Rattus norvegicus

Project description:Time course study of experimental cardiac hypertrophy in rat

| PRJNA127139 | ENA